Tweenvest Stocks

AccuStem Sciences, Inc. (OTCPK: ACUT)

Health Care · Biotechnology · US

$0.15

+9.22% today · -90.5% 1Y

AccuStem Sciences, Inc. (OTCPK: ACUT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.37M and employs 4 people.

Over the last twelve months the share price has lost 90.5%, trading between 0.12 and 1.67.

Tweenvest scores AccuStem Sciences, Inc. across four factors: quality 55/100, value 34/100. Its strongest factor is quality.

ACUT price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$2.37M
Revenue (TTM)
$98.40K
P/E
—
EPS
-0.10
Dividend yield
—
Beta (5Y)
1.89
52-week high
$1.67
52-week low
$0.12
Avg volume (3M)
—
Shares outstanding
16.07M
Employees
4
Next earnings
—

About AccuStem Sciences, Inc.

AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.

ISIN
US00444A1016
Founded
2013
Listed since
Mar 3, 2022
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Enzolytics, Inc.OTCPK: ENZC$2.42M$0.00+11.11%
Mosaic ImmunoEngineering, Inc.OTCPK: CPMV$2.41M$0.33+215.04%
Abpro Holdings, Inc.OTCPK: ABPO$2.40M$0.41+1.75%
Quest PharmaTech Inc.TSXV: QPT$2.39MCA$0.02-20.00%
Quantum Genesis AI Corp.OTCPK: QGAI$2.35M$0.06-5.12%
Matinas BioPharma Holdings, Inc.NYSEAM: MTNB$2.32M$2.37-17.42%
ValiRx plcAIM: VAL$2.29M£0.00-3.70%
Nirman Agri Genetics LimitedNSEI: NIRMAN$2.27MRs26.95+0.19%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.